Clinical Trials Browser

Phase 1 × Unilateral Breast Neoplasms × abemaciclib × Clear all

NCT04481113 2026-01-29

Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer

Phase 1 Completed

Unilateral Breast Neoplasms